NASDAQ:SLDB | Free Cash Flow | Solid Biosciences Inc.

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2016-12-31 to 2026-03-31
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2026-03-31-$47.23M$165,000.00-$47.4M
2025-12-31-$53.56M$565,000.00-$54.12M
2025-03-31-$31.85M$126,000.00-$31.98M
2024-12-31-$29.65M$204,000.00-$29.85M
2024-03-31-$25.19M$149,000.00-$25.34M
2023-12-31-$20.82M$90,000.00-$20.91M
2023-03-31-$28M$506,000.00-$28.5M
2022-12-31-$34.48M$856,000.00-$35.34M
2022-03-31-$27.19M$184,000.00-$27.37M
2021-12-31-$20.87M$660,000.00-$21.53M
2021-03-31-$21.37M$35,000.00-$21.4M
2020-12-31$1.31M$60,000.00$1.25M
2020-03-31-$29.27M$681,000.00-$29.96M
2019-12-31-$21.25M$645,000.00-$21.89M
2019-03-31-$25.93M$1.95M-$27.88M
2018-12-31-$21.4M$1.44M-$22.84M
2018-03-31-$17.17M$1M-$18.17M
2017-12-31-$13.98M$326,000.00-$14.31M
2017-03-31-$10.2M$248,000.00-$10.44M

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-12-31-$156.29M$1.15M-$157.44M
2024-12-31-$100.01M$654,000.00-$100.67M
2023-12-31-$94.18M$1.52M-$95.7M
2022-12-31-$97.98M$3.02M-$100.99M
2021-12-31-$77.76M$1.28M-$79.05M
2020-12-31-$56.6M$899,000.00-$57.5M
2019-12-31-$92.71M$4.39M-$97.1M
2018-12-31-$70.2M$7.78M-$77.97M
2017-12-31-$43.22M$2.28M-$45.5M
2016-12-31-$20.12M$392,000.00-$20.51M

Research interface only. Not investment advice. Prices are a checked-in snapshot, not live quotes.